About
Avik Arakelian is a venture investor focused on longevity, biotech, health tech, and AI-enabled healthcare. He is Partner & Head of Investments at BOLD Longevity Growth, where the firm says he has led and advised investments across more than 25 biotech and longevity companies from venture creation through IPO-stage outcomes. His prior experience includes investing and finance roles spanning Conscience VC, VITA DAO, BofA Merrill Lynch, the World Bank, the EBRD, PwC, and KPMG.
Areas of interest
longevitybiotechnologyhealth technologyartificial intelligenceAI drug discoverygene editingregenerative medicinecell therapyearly-stage diagnosticsprecision medicinevaccinesspace technologycybersecurityassistive technologyArmenian technology ecosystem